OPL-0401 - Drug Targets, Indications, Patents - Synapse
form in discovery or development,” said CEO Brian Alexander, M.D., who joined Valo and Flagship in November. “As a result, we are looking to find a partner well positioned to realize the clinical potential OPL-0401 in DR ...